Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-026072
Filing Date
2025-08-12
Accepted
2025-08-12 10:44:27
Documents
75
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q veru20250630_10q.htm   iXBRL 10-Q 1642145
2 EXHIBIT 10.1 ex_847042.htm EX-10.1 19819
3 EXHIBIT 31.1 ex_826183.htm EX-31.1 9087
4 EXHIBIT 31.2 ex_826184.htm EX-31.2 9089
5 EXHIBIT 32.1 ex_826185.htm EX-32.1 6218
  Complete submission text file 0001437749-25-026072.txt   7874649

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA veru-20250630.xsd EX-101.SCH 65418
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE veru-20250630_cal.xml EX-101.CAL 59359
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20250630_def.xml EX-101.DEF 529794
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20250630_lab.xml EX-101.LAB 426928
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20250630_pre.xml EX-101.PRE 549358
78 EXTRACTED XBRL INSTANCE DOCUMENT veru20250630_10q_htm.xml XML 1171420
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 251204995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)